Both in Biotechnology
Alector vs Lineage Cell Therapeutics
Over the past year ALEC returned +49.3% and LCTX returned −48.5%; their daily moves had a correlation of 0.30.
ALEC +49.3% LCTX −48.5%Growth of $1, one year, split-adjusted
| Metric | ALEC | LCTX |
|---|---|---|
| Price | $2.15 | $1.01 |
| Market cap | $240.1M | $255.4M |
| Today | −2.71% | +1.00% |
| 1 month | +18.8% | +8.6% |
| 6 months | −14.3% | −28.9% |
| Year to date | +37.8% | −39.5% |
| 1 year | +41.4% | −45.1% |
| Revenue growth (YoY) | −57.8% | −61.3% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −692.5% | 138.6% |
| P/E (TTM) | — | — |
| Price / sales | 17.3× | 19.5× |
| Net cash | $162.9M | $50.8M |
| Dividend yield | — | — |
| Volatility (60d) | 93.4% | 52.7% |
| Short % of float | 11.1% | 12.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).